Randox Laboratories have recently developed a COVID-19 qPCR assay, which can be used for the detection of nucleic acid from 2019-Novel Coronavirus (SARS-CoV-2) and Severe Acute Respiratory Syndrome ((SARS)/SARS-like) viruses. PCR based assays are recommended to include two tests. One to detect a universal SARS-like gene and a secondary confirmatory test for gene sequences exclusive to SARS-CoV-2.  Designed to provide detection of two pathogens, SARS-CoV-2 (ORF1ab) and Sarbecovirus (SARS, SARS like, SARS-CoV-2) (E-gene) in a multiplex format, the Randox qPCR assay allows for differentiation of SARS-CoV-2 and SARS-like corona infections from other seasonal respiratory illnesses caused by viruses to prevent rapid spread of infection through the isolation of positive cases.

Our assay is compatible with sample matrices including nasal / throat swabs. This test is intended for use in the clinical setting as an aid in the screening and isolation of individuals that require quarantine and immediate intervention.

** When extracted with KingFisher™Flex. The COVID-19 qPCR Assay requires the use of a suitable nucleic acid extraction procedure which is not supplied in the kit. This kit is currently validated for use with the Perkin Elmer Chemagic™ Viral 300 DNA/RNA kit Special H96 on the Chemagic™ 360 instrument.